BSE Live
Oct 16, 16:01Prev. Close
3532.25
Open Price
3532.30
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 16, 15:56Prev. Close
3532.80
Open Price
3535.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
3533.80 (183)
Key Financial Ratios of Torrent Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
Per Share Ratios | ||||||
Basic EPS (Rs.) | 56.47 | 48.94 | 36.79 | 45.93 | 73.98 | |
Diluted EPS (Rs.) | 56.47 | 48.94 | 36.79 | 45.93 | 73.98 | |
Cash EPS (Rs.) | 79.96 | 72.82 | 57.67 | 85.05 | 112.84 | |
Book Value [ExclRevalReserve]/Share (Rs.) | 224.27 | 202.57 | 183.13 | 351.75 | 344.90 | |
Book Value [InclRevalReserve]/Share (Rs.) | 224.27 | 202.57 | 183.13 | 351.75 | 344.90 | |
Revenue from Operations/Share (Rs.) | 340.25 | 316.96 | 284.23 | 502.72 | 472.97 | |
PBDIT/Share (Rs.) | 110.63 | 101.21 | 85.30 | 155.27 | 149.90 | |
PBIT/Share (Rs.) | 87.14 | 77.33 | 64.43 | 116.15 | 111.04 | |
PBT/Share (Rs.) | 78.97 | 69.49 | 54.58 | 72.44 | 90.18 | |
Net Profit/Share (Rs.) | 56.47 | 48.94 | 36.79 | 45.92 | 73.97 | |
NP After MI And SOA / Share (Rs.) | 56.47 | 48.94 | 36.79 | 45.92 | 73.97 | |
Profitability Ratios | ||||||
PBDIT Margin (%) | 32.51 | 31.93 | 30.01 | 30.88 | 31.69 | |
PBIT Margin (%) | 25.61 | 24.39 | 22.66 | 23.10 | 23.47 | |
PBT Margin (%) | 23.20 | 21.92 | 19.20 | 14.40 | 19.06 | |
Net Profit Margin (%) | 16.59 | 15.44 | 12.94 | 9.13 | 15.63 | |
NP After MI And SOA Margin (%) | 16.59 | 15.44 | 12.94 | 9.13 | 15.63 | |
Return on Networth/Equity (%) | 25.17 | 24.15 | 20.09 | 13.05 | 21.44 | |
Return on Capital Employed (%) | 28.71 | 27.16 | 22.79 | 22.63 | 20.46 | |
Return on Assets (%) | 12.75 | 10.99 | 8.29 | 5.93 | 8.89 | |
Total Debt/Equity (X) | 0.40 | 0.57 | 0.85 | 0.67 | 0.83 | |
Asset Turnover Ratio (%) | 0.77 | 0.71 | 0.68 | 0.53 | 0.50 | |
Liquidity Ratios | ||||||
Current Ratio (X) | 1.19 | 1.03 | 0.98 | 1.20 | 1.13 | |
Quick Ratio (X) | 0.65 | 0.61 | 0.57 | 0.64 | 0.58 | |
Inventory Turnover Ratio (X) | 4.70 | 0.74 | 0.63 | 0.68 | 0.70 | |
Dividend Payout Ratio (NP) (%) | 56.66 | 61.29 | 69.30 | 87.09 | 27.03 | |
Dividend Payout Ratio (CP) (%) | 40.02 | 41.19 | 44.21 | 47.02 | 17.72 | |
Earnings Retention Ratio (%) | 43.34 | 38.71 | 30.70 | 12.91 | 72.97 | |
Cash Earnings Retention Ratio (%) | 59.98 | 58.81 | 55.79 | 52.98 | 82.28 | |
Coverage Ratios | ||||||
Interest Coverage Ratios (%) | 14.84 | 9.69 | 8.66 | 10.30 | 7.19 | |
Interest Coverage Ratios (Post Tax) (%) | 14.84 | 9.69 | 8.66 | 10.30 | 7.19 | |
Valuation Ratios | ||||||
Enterprise Value (Cr.) | 111,924.90 | 91,136.90 | 56,758.99 | 50,939.27 | 47,229.23 | |
EV/Net Operating Revenue (X) | 9.72 | 8.50 | 5.90 | 5.99 | 5.90 | |
EV/EBITDA (X) | 29.89 | 26.60 | 19.66 | 19.38 | 18.62 | |
MarketCap/Net Operating Revenue (X) | 9.51 | 8.21 | 5.41 | 5.56 | 5.37 | |
Retention Ratios (%) | 43.33 | 38.70 | 30.69 | 12.90 | 72.96 | |
Price/BV (X) | 14.42 | 12.84 | 8.40 | 7.95 | 7.37 | |
Price/Net Operating Revenue | 9.51 | 8.21 | 5.41 | 5.56 | 5.37 | |
Earnings Yield | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 |
29.09.2025
Chartist Talk: Nifty 50 faces make-or-break 24,500 support, charts flash warning signs
24.09.2025
11.09.2025
01.09.2025
29.07.2025
Torrent Pharma Consolidated June 2025 Net Sales at Rs 3,178.00 crore, up 11.16% Y-o-Y
29.07.2025
Torrent Pharma Standalone June 2025 Net Sales at Rs 2,616.00 crore, up 7.3% Y-o-Y
21.05.2025
Torrent Pharma Standalone March 2025 Net Sales at Rs 2,433.00 crore, up 13.53% Y-o-Y
28.01.2025
Torrent Pharma Consolidated December 2024 Net Sales at Rs 2,809.00 crore, up 2.82% Y-o-Y
12.07.2023
Torrent Pharma Q1 PAT may dip 9.7% YoY to Rs 319.7 cr: Nirmal Bang
17.01.2023
Torrent Pharma Q3 PAT seen up 28.9% YoY to Rs 3,211 cr: Nirmal Bang
13.07.2022
Torrent Pharma Q1 PAT seen up 2.8% YoY to Rs 339.1 cr: ICICI Direct
08.07.2022
Torrent Pharmaceuticals Q1 PAT seen up 1.4% YoY to Rs 334.5 cr: Prabhudas Lilladher
24.07.2019
Torrent Pharma shares jump 6% as brokerages remain bullish after Q1 show
25.08.2018
Pharma Q1 review: Brokerages say performance a mixed bag, but are upbeat on domestic biz
22.01.2014
14.01.2012